Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (821-830 of 13,985) with videos related to

Pageof 1,399
Sort By:
Leukemia|November 27, 2010
Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytesC R Giver, D L Jaye, E K Waller, et al.
Leukemia|September 4, 2009
Cranial irradiation does not result in pituitary-gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemiaN J van Casteren, R Pieters, G R Dohle, et al.
Leukemia|May 19, 2009
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21D Rossi, S Rasi, S Franceschetti, et al.
Leukemia|April 9, 2010
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myelomaA Palumbo, A Larocca, P Falco, et al.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Leukemia|May 21, 2010
Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)A Pardanani, M M Patnaik, T L Lasho, et al.
Leukemia|May 21, 2010
MOZ-TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2K B Kindle, H M Collins, D M Heery
Leukemia|April 23, 2010
WT1 protein is a transcriptional activator of the antiapoptotic bag3 geneE Cesaro, G Montano, A Rosati, et al.
Leukemia|April 23, 2010
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progressionJ Boultwood, J Perry, R Zaman, et al.
Leukemia|May 7, 2010
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinibS Redaelli, F Boschelli, P Perini, et al.
Pageof 1,399

Showing results (821-830 of 13,985) with videos related to

Sort By:
Pageof 1,399
Leukemia|November 27, 2010
Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytesC R Giver, D L Jaye, E K Waller, et al.
Leukemia|September 4, 2009
Cranial irradiation does not result in pituitary-gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemiaN J van Casteren, R Pieters, G R Dohle, et al.
Leukemia|May 19, 2009
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21D Rossi, S Rasi, S Franceschetti, et al.
Leukemia|April 9, 2010
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myelomaA Palumbo, A Larocca, P Falco, et al.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Leukemia|May 21, 2010
Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)A Pardanani, M M Patnaik, T L Lasho, et al.
Leukemia|May 21, 2010
MOZ-TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2K B Kindle, H M Collins, D M Heery
Leukemia|April 23, 2010
WT1 protein is a transcriptional activator of the antiapoptotic bag3 geneE Cesaro, G Montano, A Rosati, et al.
Leukemia|April 23, 2010
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progressionJ Boultwood, J Perry, R Zaman, et al.
Leukemia|May 7, 2010
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinibS Redaelli, F Boschelli, P Perini, et al.
Pageof 1,399